Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 310

Similar articles for PubMed (Select 16168124)

1.

High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.

Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG.

Breast Cancer Res. 2005;7(5):R780-7. Epub 2005 Jul 28.

2.

Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.

Gong YP, Yarrow PM, Carmalt HL, Kwun SY, Kennedy CW, Lin BP, Xing PX, Gillett DJ.

Eur J Surg Oncol. 2007 May;33(4):438-43. Epub 2006 Nov 27.

PMID:
17125961
3.
4.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

5.

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.

Madjd Z, Spendlove I, Pinder SE, Ellis IO, Durrant LG.

Int J Cancer. 2005 Nov 1;117(2):248-55.

PMID:
15900607
6.

Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.

Shabani N, Mylonas I, Kunert-Keil C, Briese V, Janni W, Gerber B, Friese K, Jeschke U.

Anticancer Res. 2005 May-Jun;25(3A):1761-4.

7.

Breast cancer progression and expression of blood group-related tumor-associated antigens.

Steplewska-Mazur K, Gabriel A, Zajecki W, Wylezoł M, Glück M.

Hybridoma. 2000 Apr;19(2):129-33.

PMID:
10868792
8.

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

Travis A, Pinder SE, Robertson JF, Bell JA, Wencyk P, Gullick WJ, Nicholson RI, Poller DN, Blamey RW, Elston CW, Ellis IO.

Br J Cancer. 1996 Jul;74(2):229-33.

9.

Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival.

Galiègue S, Casellas P, Kramar A, Tinel N, Simony-Lafontaine J.

Clin Cancer Res. 2004 Mar 15;10(6):2058-64.

12.

Loss of CD59 expression in breast tumours correlates with poor survival.

Madjd Z, Pinder SE, Paish C, Ellis IO, Carmichael J, Durrant LG.

J Pathol. 2003 Aug;200(5):633-9.

PMID:
12898600
13.

Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomas.

Tauchi K, Kakudo K, Machimura T, Makuuchi H, Mitomi T.

Cancer. 1991 Jun 15;67(12):3042-50.

PMID:
2044050
14.

Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.

Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W.

J Pathol. 2002 Oct;198(2):181-9.

PMID:
12237877
15.

The prognosis of small primary breast cancers.

Kollias J, Murphy CA, Elston CW, Ellis IO, Robertson JF, Blamey RW.

Eur J Cancer. 1999 Jun;35(6):908-12.

PMID:
10533470
16.

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Köchli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G.

Breast Cancer Res Treat. 2004 Aug;86(3):207-13.

PMID:
15567937
17.
18.

[Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].

Larena A, Vierbuchen M, Schröder S, Larena-Avellaneda A, Hadshiew I, Fischer R.

Langenbecks Arch Chir. 1996;381(2):102-13. German.

PMID:
8649124
19.

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.

Breast Cancer Res. 2008;10(5):R86. doi: 10.1186/bcr2156. Epub 2008 Oct 16.

20.

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO.

Histopathology. 2005 Jun;46(6):685-93.

PMID:
15910600
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk